Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Lumba-Brown is an academic pediatric emergency medicine physician with expertise in neuroscience and neurocritical emergencies. She cares for children and young adults clinically in the Stanford Pediatric Emergency Department. Dr. Lumba-Brown is a national expert on traumatic brain injury and has led several large clinical care guidelines. She sits on the Board of Scientific Counselors for the Centers for Disease Control’s (CDC) National Center for Injury Prevention and Control, a federal advisory committee. She is also an appointee to the Pac-12 Brain Trauma Task Force, guiding research and policy in athletes with head injury. Dr. Lumba-Brown is the co-director of the Stanford Brain Performance Center where she works to advance the neuroscience of childhood development, injury, and aging through prevention, novel biomarker discovery and other diagnostics, and treatments.
Centers for Disease Control and Injury Prevention
Dr. Lumba-Brown is a specialty-trained, board-certified pediatric emergency medicine physician working clinically in the Stanford Emergency Department and co-directing the Stanford Brain Performance Center. <br/><br/>Her research focuses on traumatic brain injury and brain performance. Dr. Lumba-Brown’s previous scholarly work include: a prospective, double-blinded, randomized controlled trial evaluating therapeutic intervention in acute pediatric concussion (Peds Em Care 2014); complicated mild TBI risk score development (Pediatrics and others 2017); and a large systematic review and CDC guideline publication (JAMA Peds and others 2018); concussion subtype classification (Neurosurgery 2019 and others). Her current areas of active research include investigations of diagnosis, management, and therapeutic intervention in traumatic brain injury, subtype classification of concussion, and the pre-hospital management of mild-severe TBI. She also studies brain performance via sensorimotor and sensory-cognitive synchronization to address attentional impairments.
Hypertonic Saline as Therapy for Pediatric Concussion
This single center, blinded, randomized controlled trial evaluated the use of hypertonic
saline versus normal saline as therapy for the symptoms of pediatric concussion post head
The study hypothesis was that hypertonic saline would improve symptoms of pediatric
concussion following head injury as measured on the self-reported Wong Baker Faces Pain Scale
as compared to normal saline.
The null hypothesis was that there would be no difference in change of reported pain in
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details